Endpoint Health Raises $52 Million in Financing to Expand and Progress Precision Immunology Pipeline
PALO ALTO, Calif.--(BUSINESS WIRE)--Endpoint Health, Inc., a Precision-FirstTM therapeutics company dedicated to addressing unmet needs in immune-mediated acute and chronic diseases, today announced the close of $52 million in equity and debt financing. Major institutional investors participating in the Series A round included Mayfield, Humboldt Fund, AME Cloud Ventures, Boom...
